Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM

Journal of Diabetes and its Complications

Volumn 15, Issue 4, 2001, Pages 185-192

  Kaňková, Kateřina ^a   Záhejský, Jiří ^a   Márová, Ivana ^a   Mužík, Jan ^a   Kuhrová, Viera ^a   Blažková, Michaela ^a   Znojil, Vladimír ^a   Beránek, Michal ^a   Vácha, Jiří ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Diabetes associated dermatoses; Diabetic complications; Diabetic microangiopathy; Genetic polymorphism; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CAUCASIAN; CHEMISTRY; COMPARATIVE STUDY; CZECH REPUBLIC; DIABETIC ANGIOPATHY; EXON; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MICROCIRCULATION; MIDDLE AGED; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; POINT MUTATION; SKIN; SKIN DISEASE; VASCULARIZATION;

AGED; AMINO ACID SUBSTITUTION; CZECH REPUBLIC; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MUTATION, MISSENSE; POINT MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; SEQUENCE DELETION; SKIN; SKIN DISEASES;

EID: 0035405839     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(00)00135-5     Document Type: Article

References (27)

1. Allen, G. E. (1969). Diabetes mellitus and the skin. Practitioner 203, 189-193.
2. Braverman, I. M., & Keh-Yen, A. (1984). Ultrastructural abnormalities of the microvasculature and elastic fibres in the skin of juvenile diabetics. J Invest Dermatol 82, 270-274.
3. Cole, G. W., Headley, J., & Skowsky, R. (1983). Scleredema diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care 6, 189-192.
4. Delbridge, L., Ellis, C. S., Robertson, K., & Lequesne, L. P. (1985). Nonenzymatic glycosylation of keratin from the stratum corneum of the diabetic foot. B J Dermatol 112, 547-554.
5. Gilgor, R. S., & Lazarus, G. S. (1981). Skin manifestations of diabetes mellitus. In: H. Rifkin, & P. Raskin (Eds.), Diabetes Mellitus (Vol. 5, pp. 313-322). Bowie, MD: RJ Brody.
6. Hödl, S. (1992). Skin disorders in diabetes mellitus. A review of the diabetes associated dermatoses and their implications for other disorders. Acta Dermatovenerol 1, 71-76.
7. Hudson, B. I., Stickland, M. H., & Grant, P. J. (1998). Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene. Diabetes 47, 1155-1157.
8. Kaňková, K., Blažková, M., & Márová, I. (1998). Genetic polymorphism of RAGE and diabetic late skin complications. Pathophysiology 5(suppl. 1), 175 (Abstract).
9. Kaňková, K., Vašků, A., Hájek, D., Záhejský, J., & Vašků, V. (1999). Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care 22, 1745.
10. Liu, L., & Xiang, K. (1999). RAGE Gly82Ser polymorphism in diabetic microangiopathy. Diabetes Care 22, 646.
11. Márová, I., Záhejský, J., & Sehnalová, H. (1995). Non-enzymatic glycation of epidermal proteins of the stratum corneum in diabetic patients. Acta Diabetol 32, 38-43.
12. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. E., Elliston, K., Stern, D., & Shaw, A. (1992). Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267, 14998-15004.
13. Perez, M. I., & Kohn, S. R. (1994). Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 30, 519-531.
14. Raskin, P. (1994). Risk factors for the development of diabetic complications. J Diabetes Complications 8, 195-200.
15. Raskin, P. (1996). Susceptibility to diabetic complications. J Diabetes Complications 10, 61.
16. Salmela, P. I., Oikarinen, A. I., Ukkola, O., Karjalainen, A., Lannaluoto, M., Puukka, R., & Ryhänen, L. (1995). Improved metabolic control in patients with non-insulin dependent diabetes mellitus is associated with slower accumulation of glycation products in collagen. Eur J Clin Invest 25, 494-500.
17. Seaquist, E. R., Frederick, M. D., Goetz, F. C., Rich, S., & Barbosa, J. (1989). Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320, 1161-1165.
18. Sibbald, R. G., Landolt, S. J., & Toth, D. (1996). Skin and diabetes. Endocrinol Metab Clin North Am 25, 463-472.
19. Soulis, T., Thallas, V., Youssef, S., Gillbert, R. E., McWilliam, B. G., Murray-McIntosh, R. P., & Cooper, M. E. (1997). Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 40, 619-628.
20. Sugaya, K., Fukagawa, T., Matsumoto, K., Mita, K., Takahashi, E., Ando, A., Inoko, H., & Ikemura, T. (1994). Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a NOTCH homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 23, 408-419.
21. The DCCT Research Group. (1997). Clustering of long term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 46, 1829-1839.
22. The Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329, 977-986.
23. UK Prospective Diabetes Study Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853.
24. Vašků, V., Vašků, A., Hollá, L., Kaňková, K., Znojil, V, Semrádová, V., & Vácha, J. (1999). Interaction of five gene polymorphisms at psoriasis. J Invest Dermatol 113, 494 (Abstract).
25. Vishwanath, V., Frank, K. E., Elmets, C. A., Dauchot, P. J., & Monnier, V. M. (1986). Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications. Diabetes 35, 916-921.
26. Visiiing, H., Aagaard, L., Tommerup, N., & Boel, E. (1994). Localisation of the human gene for advanced glycosylation end products-specific receptor (AGER) to chromosome 6p21.3. Genomics 24, 606-608.
27. Yasuda, H., Taniguchi, Y., Yamashita, M., Kobayashi, N., Sonobe, M., Hatanaka, I., Kikkawa, R., & Shigeta, Y (1990). Morphological characteristics of dermal diabetic microangiopathy. Diabetes Res Clin Pract 9, 187-194.